Picture of AbbVie logo

ABBV — AbbVie News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

AbbVie's blood cancer drug meets late-stage trial goals

AbbVie's blood cancer drug meets late-stage trial goals

- AbbVie ABBV.N said on Thursday its drug for a type of blood cancer has met the main goals of a late-stage trial.


(Reporting by Puyaan Singh in Bengaluru; Editing by Shilpi Majumdar)

((Puyaan.Singh@thomsonreuters.com;))

Recent news on AbbVie

See all news